ArticleBreast cancer research : BCR2026

CAF-derived exosomes drive trastuzumab resistance in HER2-positive breast cancer via YAP-USP8-HER2 axis activation.

Weijia Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.